Kentaro Ouchi

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Prognostic Factors

Cardiovascular Events

Top Venues

Emerging microbes & infections

Antimicrobial agents and chemotherapy

Otsuka Pharmaceutical

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Otsuka Pharmaceutical Feb 01 2011

Japan

Chief, Medical Communication :: Medical Affaires

Santen Seiyaku Kabushiki Kaisha Apr 01 1993 - Jan 31 2011

Japan

Manager, Asia Clinical Development Team :: Clinical Development Center

Publications

Tanya Lew, Papanin Putsathit, Kyung Mok Sohn, Yuan Wu, Kentaro Ouchi, Yoshikazu Ishii, Kazuhiro Tateda, Thomas V Riley, Deirdre A Collins
Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015. Antimicrobial agents and chemotherapy 64 (7) (2020)
Deirdre A Collins, Kyung Mok Sohn, Yuan Wu, Kentaro Ouchi, Yoshikazu Ishii, Briony Elliott, Thomas V Riley, Kazuhiro Tateda, null null
Clostridioides difficile infection in the Asia-Pacific region. Emerging microbes & infections 9 (1) (2019)